wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q30277077-58C3E089-834E-47A9-A72B-6FA2B3B6E2D0
Q30277077-58C3E089-834E-47A9-A72B-6FA2B3B6E2D0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30277077-58C3E089-834E-47A9-A72B-6FA2B3B6E2D0
Response to post-axitinib treatment in patients with metastatic renal cell carcinoma.
P2860
Q30277077-58C3E089-834E-47A9-A72B-6FA2B3B6E2D0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30277077-58C3E089-834E-47A9-A72B-6FA2B3B6E2D0
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ddf27b0a2ae705b49f62f9a7d7d6fc401d34041c
P2860
Antitumor effects of sunitinib or sorafenib in patients with metastatic renal cell carcinoma who received prior antiangiogenic therapy.